Removing mutant p53 significantly regresses tumors, improves cancer survival

For two decades cancer researchers have looked unsuccessfully for ways to develop compounds to restore the function of mutant p53 proteins. Now a team of researchers has discovered that eliminating the abnormally stabilized mutant p53 protein in cancer in vivo has positive therapeutic effects, showing that tumors regress significantly and survival increases.